CA2394033A1 - Polymorphismes associes aux maladies enteriques inflammatoires - Google Patents
Polymorphismes associes aux maladies enteriques inflammatoires Download PDFInfo
- Publication number
- CA2394033A1 CA2394033A1 CA002394033A CA2394033A CA2394033A1 CA 2394033 A1 CA2394033 A1 CA 2394033A1 CA 002394033 A CA002394033 A CA 002394033A CA 2394033 A CA2394033 A CA 2394033A CA 2394033 A1 CA2394033 A1 CA 2394033A1
- Authority
- CA
- Canada
- Prior art keywords
- allele
- polymorphic
- nucleic acid
- polymorphisms
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des segments d'acide nucléique du génome humain, en particulier des segments d'acide nucléique issus d'un gène, comprenant des sites polymorphes. Cette invention concerne aussi des amorces et des sondes spécifiques aux allèles s'hybridant à des régions adjacentes à ces sites ou contenant ces sites . On utilise ces acides nucléiques, ces amorces et ces sondes dans des applications telles que les corrélations phénotypiques, la médecine légale, la recherche de paternité, la médecine et les analyses génétiques.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17025799P | 1999-12-10 | 1999-12-10 | |
US60/170,257 | 1999-12-10 | ||
US19604600P | 2000-04-10 | 2000-04-10 | |
US60/196,046 | 2000-04-10 | ||
PCT/US2000/033632 WO2001042511A2 (fr) | 1999-12-10 | 2000-12-11 | Polymorphismes associes aux maladies enteriques inflammatoires |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2394033A1 true CA2394033A1 (fr) | 2001-06-14 |
Family
ID=26865891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002394033A Abandoned CA2394033A1 (fr) | 1999-12-10 | 2000-12-11 | Polymorphismes associes aux maladies enteriques inflammatoires |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1276899A2 (fr) |
AU (1) | AU2258601A (fr) |
CA (1) | CA2394033A1 (fr) |
WO (1) | WO2001042511A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3885400A (en) * | 1999-03-23 | 2000-10-09 | Human Genome Sciences, Inc. | 48 human secreted proteins |
AU2002348745A1 (en) * | 2001-12-21 | 2003-07-09 | Ellipsis Biotherapeutics Corporation | Polymorphisms of the OCTN1 and OCTN2 cation transporters associated with inflammatory bowel disease |
WO2010062960A2 (fr) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d’une maladie intestinale inflammatoire |
EP3639841B1 (fr) | 2013-03-27 | 2023-09-06 | Cedars-Sinai Medical Center | Traitement de la fibrose par inhibition de tl1a |
EP4105236A1 (fr) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anticorps contre tl1a (tnfsf15) pour le traitement des maladies inflammatoires de l'intestin |
WO2017161342A1 (fr) | 2016-03-17 | 2017-09-21 | Cedars-Sinai Medical Center | Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2 |
CN108359736B (zh) * | 2018-05-23 | 2020-12-29 | 华中农业大学 | 母猪肢蹄骨密度性状的snp遗传标记 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE930961L (en) * | 1984-07-06 | 1986-01-06 | Sandoz Ag | Lymphokine production and purification |
WO1994004196A1 (fr) * | 1992-08-14 | 1994-03-03 | Imperial Cancer Research Technology Limited | Therapie de tumeurs |
US5681699A (en) * | 1994-02-11 | 1997-10-28 | Cedars-Sinai Medical Center | Methods of diagnosing ulcerative colitis and Crohn's disease |
US5916748A (en) * | 1996-04-12 | 1999-06-29 | Cedars-Sinai Medical Center | Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis |
EP0941366A2 (fr) * | 1996-11-06 | 1999-09-15 | Whitehead Institute For Biomedical Research | Marqueurs bialleliques |
WO1998038846A2 (fr) * | 1997-03-07 | 1998-09-11 | Affymetrix, Inc. | Compositions genetiques et procedes |
-
2000
- 2000-12-11 CA CA002394033A patent/CA2394033A1/fr not_active Abandoned
- 2000-12-11 AU AU22586/01A patent/AU2258601A/en not_active Abandoned
- 2000-12-11 WO PCT/US2000/033632 patent/WO2001042511A2/fr not_active Application Discontinuation
- 2000-12-11 EP EP00986325A patent/EP1276899A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2001042511A2 (fr) | 2001-06-14 |
WO2001042511A3 (fr) | 2002-11-14 |
EP1276899A2 (fr) | 2003-01-22 |
AU2258601A (en) | 2001-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0955382A2 (fr) | Des polymorphismes associés à l'hypertension | |
US6869762B1 (en) | Crohn's disease-related polymorphisms | |
WO2008070074A2 (fr) | Marqueurs génétiques de la schizophrénie | |
KR101633783B1 (ko) | Cyp3a5 및 cyp3a7 유전자 부위의 염기서열 다형성을 이용한 타크로리무스 혈중 약물 농도 예측 방법 | |
WO1998018967A1 (fr) | Polymorphismes dans le locus de la glucose-6-phosphate-deshydrogenase | |
WO1998038846A2 (fr) | Compositions genetiques et procedes | |
EP1731608A1 (fr) | Gene marqueur pour examen d'arthrorhumatisme | |
WO2001066800A2 (fr) | Polymorphismes humains a nucleotide unique | |
WO2005112568A2 (fr) | Marqueurs haplotypes et procedes d'utilisation de ceux-ci pour determiner la reponse a un traitement | |
US20030170665A1 (en) | Haplotype map of the human genome and uses therefor | |
CA2394033A1 (fr) | Polymorphismes associes aux maladies enteriques inflammatoires | |
AU3363899A (en) | Coding sequence polymorphisms in vascular pathology genes | |
EP1262565A2 (fr) | Polymorphismes génétiques dans le gène humain du récepteur de la neurokinine 1 et leurs usages dans diagnostic et traitement de maladies | |
WO2000058519A2 (fr) | Caracterisation de polymorphismes d'un seul nucleotide, dans des regions de codage de genes humains | |
WO1998058529A2 (fr) | Compositions genetiques et procedes correspondants | |
EP1068354A2 (fr) | Marqueurs bialleliques | |
EP1024200A2 (fr) | Compositions génétiques et procédés | |
WO2001038576A2 (fr) | Polymorphismes humains a nucleotide unique | |
US20030224365A1 (en) | Single nucleotide polymorphisms diagnostic for schizophrenia | |
WO1999014228A1 (fr) | Compositions genetiques et procedes | |
WO2003020980A2 (fr) | Polymorphismes nucleotidiques simples permettant le diagnostic de la schizophrenie | |
WO2001034840A2 (fr) | Compositions genetiques et methodes associees | |
US20030170679A1 (en) | Single nucleotide polymorphisms in GH-1 | |
US7671182B2 (en) | Gene variants of signal transducer and activator of transcription-6 (STAT 6) variants and process of detection the same | |
CA2427214A1 (fr) | Procedes d'evaluation du risque de diabete sucre non insulino-dependant sur la base de variations alleliques dans la zone marginale 5' du gene de l'insuline et des tissus adipeux |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |